Advertisement

Canadian Gastrointestinal Society calling out B.C. for being slow to approve drugs

Click to play video: 'B.C. government urged to change requirements for inflammatory bowel disease drugs'
B.C. government urged to change requirements for inflammatory bowel disease drugs
A Canadian health advocacy group is urging the B.C. government to change a policy it says makes it difficult for people who suffer from inflammatory bowel disease to get the most effective treatments. Aaron McArthur reports – Apr 27, 2026

Another health group is calling out the B.C. government for being slow to green light drugs that are approved in other provinces in Canada.

The Canadian Gastrointestinal Society says doctors treating inflammatory bowel disease in B.C. are often required to first try older, less effective medications that can have costly side effects.

They can access advanced treatments only if the older medications fail.

“I guess the government calls it cost savings because they don’t want to pay the big price of these advanced therapies that are more expensive,” Gail Attara, CEO of the Canadian Gastrointestinal Society told Global News.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

“But the reality is the longer you wait to treat someone, the worse their disease becomes.”

The GI Society claims that in many cases, a doctor will prescribe an older medication and tell the patient to throw it out — sometimes multiple times — to get to the medication they actually need, because the older medications will do more harm than good.

Story continues below advertisement
Click to play video: 'BC denies funding for drug to help treat rare blood disorder'
BC denies funding for drug to help treat rare blood disorder

B.C. Health Minister Josie Osborne said the government is always looking at the evidence first.

“Here in B.C., we have one of the most robust pharmacare programs covering a wide range of different pharmaceuticals to help British Columbians,” she said.

“We are always looking at the evidence; we work closely, of course, with the federal government on that.”

Sponsored content

AdChoices